SCHEMBL18540543

SCHEMBL18540543

CC(=O)CSc1nnc(-c2cccc(C(=O)Nc3ccc4ncccc4c3)c2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.52
RAB9A P51151 5/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
PABPC1 P11940 1/20 0.52
POLB P06746 2/20 0.49
PARP1 P09874 1/20 0.44
BRAF P15056 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MMP9 P14780 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17213024 0.92 PABPC1 (0.55) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL21763899 0.90 NPC1 (0.52) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL18540510 0.84 KMT2A (0.53) NPC1RAB9APOLBALDH1A1MAPT
SCHEMBL18540535 0.83 SMN1; SMN2 (0.49) NPC1RAB9APOLBALDH1A1MAPT
SCHEMBL18540599 0.81 POLB (0.48) NPC1RAB9ACASP3SENP7POLB
SCHEMBL18540519 0.79 GRK6 (0.51) POLBMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL18540553 0.76 RAB9A (0.41) NPC1RAB9APOLBALDH1A1MAPT
SCHEMBL18540569 0.75 NPC1 (0.45) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL17213099 0.75 NPC1 (0.51) NPC1RAB9APOLBPARP1ALDH1A1
SCHEMBL17212991 0.75 GRK6 (0.44) NPC1RAB9APOLBPARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 NPC1 4476/4885RAB9A 1688/4885CASP3 3482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.